Center for Scientific Review; Amended Notice of Meeting, 4667-4668 [2018-02031]
Download as PDF
<![CDATA[
sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 22 / Thursday, February 1, 2018 / Notices
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–875–2215,
qinmei@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Fogarty Global Brain Disorders.
Date: March 1–2, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW, Washington, DC 20036.
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Neurodevelopment, Synaptic
Plasticity and Neurodegeneration.
Date: March 1–2, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Old Town, 625 First
Street, Alexandria, VA 22314.
Contact Person: Mary Schueler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7846, Bethesda, MD 20892, 301–451–
0996, marygs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AIDS and
AIDS-related applications.
Date: March 1, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
Bethesda, MD 20892, 301–451–5953, tuoj@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Systems Science and Health in the
Behavioral and Social Sciences.
Date: March 1, 2018.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Ping Wu, Ph.D., Scientific
Review Officer, HDM IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
Bethesda, MD 20892, 301–451–8428, wup4@
csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Biostatistical Methods and Research Design
Study Section.
Date: March 1, 2018–March 2, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
VerDate Sep<11>2014
19:34 Jan 31, 2018
Jkt 244001
Contact Person: Peter J. Kozel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
Bethesda, MD 20892, 301–435–1116, kozelp@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR:
Selected Topics in Transfusion Medicine.
Date: March 1–2, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9497, zouai@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Genetics
of Health and Disease Study Section.
Date: March 1–2, 2018.
Time: 10:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Cheryl M. Corsaro, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204,
MSC 7890, Bethesda, MD 20892, (301) 435–
1045, corsaroc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 16–
234: Accelerating the Pace of Drug Abuse
Research Using Existing Data.
Date: March 1, 2018.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kate Fothergill, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 3142,
Bethesda, MD 20892, 301–435–2309,
fothergillke@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Nursing and Related Clinical
Sciences.
Date: March 1, 2018.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Karin F. Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
MSC 7770, Bethesda, MD 20892, 301–254–
9975, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Skeletal Biology and Disease.
Date: March 1, 2018.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
4667
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Maria Nurminskaya, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, Bethesda, MD 20892, (301) 435–1222,
nurminskayam@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 26, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–01954 Filed 1–31–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Macromolecular
Structure and Function C Study Section,
February 8, 2018, 8:00 a.m. to February
9, 2018, 5:00 p.m., The Darcy Hotel,
1515 Rhode Island Avenue,
Washington, DC 20005 which was
published in the Federal Register on
January 11, 2018, V 83 Pg. 1376.
The meeting will be held February 8,
2018 at 8:00 a.m. and end 8:00 p.m. The
meeting location remains the same. The
meeting is closed to the public.
Dated: January 29, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–02033 Filed 1–31–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Skeletal Muscle and
Exercise Physiology Study Section,
February 8, 2018, 8:00 a.m. to February
9, 2018, 6:00 p.m., Hilton Long Beach
and Executive Center, 701 West Ocean
Boulevard, Long Beach, CA 90831
which was published in the Federal
Register on January 19, 2018, 83 FR PG
2807.
E:\FR\FM\01FEN1.SGM
01FEN1
4668
Federal Register / Vol. 83, No. 22 / Thursday, February 1, 2018 / Notices
The meeting will be held on February
7, 2018 at 6:00 p.m. and end February
8, 2018 9:00 p.m. The meeting location
remains the same. The meeting is closed
to the public.
Dated: January 29, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–02031 Filed 1–31–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Nanotechnology
Study Section, February 8, 2018, 8:00
a.m. to February 9, 2018, 5:00 p.m.,
Baltimore Marriott Waterfront, 700
Aliceanna Street, Baltimore, MD 21202
which was published in the Federal
Register on January 5, 2018, V–83 Pg.
683.
The meeting will be held on February
7, 2018 at 7:00 p.m. and end February
9, 2018 at 5:00. The meeting location
remains the same. The meeting is closed
to the public.
Dated: January 29, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–02034 Filed 1–31–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
sradovich on DSK3GMQ082PROD with NOTICES
Advisory Committee for Women’s
Services (ACWS); Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given of a meeting of
the Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Advisory Committee for Women’s
Services (ACWS) on February 14, 2018.
The meeting will include discussions
on assessing SAMHSA’s current
strategies related to women
experiencing homelessness with
behavioral health needs, and
SAMHSA’s strategies related to women
in the criminal justice system with
behavioral health needs. Additionally,
the ACWS will be speaking with the
Assistant Secretary of Mental Health
and Substance Use regarding priorities
VerDate Sep<11>2014
19:34 Jan 31, 2018
Jkt 244001
and directions around behavioral health
services and access for women and
children.
The meeting is open to the public and
will be held at SAMHSA, 5600 Fishers
Lane, Rockville, MD, 20857, in
Conference Room 5E29. Attendance by
the public will be limited to space
available. Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions should be forwarded to the
contact person (below) by February 5,
2018. Oral presentations from the public
will be scheduled at the conclusion of
the meeting. Individuals interested in
making oral presentations are
encouraged to notify the contact person
on or before February 5, 2018. Five
minutes will be allotted for each
presentation.
The meeting may be accesed via
telephone. To attend on site, obtain the
call-in number and access code, submit
written or brief oral comments, or
request special accommodations for
persons with disabilities, please register
on-line at https://nac.samhsa.gov/
Registration/meetingsRegistration.aspx,
or communicate with SAMHSA’s
Designated Federal Officer, Ms. Valerie
Kolick (see contact information below).
Substantive meeting information and
a roster of ACWS members may be
obtained either by accessing the
SAMHSA Committees’ Web https://
www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting Ms.
Kolick.
Committee Name: Substance Abuse
and Mental Health Services
Administration Advisory Committee for
Women’s Services (ACWS).
Date/Time/Type: Wednesday,
February 14, 2018, from: 9:00 a.m. to
4:45 p.m. EDT, Open.
Place: SAMHSA, 5600 Fishers Lane,
Conference Room 5E29, Rockville,
Maryland 20857.
Contact: Valerie Kolick, Designated
Federal Official, SAMHSA’s Advisory
Committee for Women’s Services, 5600
Fishers Lane, Rockville, MD 20857,
Telephone: (240) 276–1738, Email:
Valerie.kolick@samhsa.hhs.gov.
Carlos Castillo,
Committee Management Officer, Substance
Abuse and Mental Health, Services
Administration.
[FR Doc. 2018–02010 Filed 1–31–18; 8:45 am]
BILLING CODE 4162–20–P
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of HHS-Certified
Laboratories and Instrumented Initial
Testing Facilities Which Meet Minimum
Standards To Engage in Urine Drug
Testing for Federal Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) notifies federal
agencies of the laboratories and
Instrumented Initial Testing Facilities
(IITF) currently certified to meet the
standards of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines).
A notice listing all currently HHScertified laboratories and IITFs is
published in the Federal Register
during the first week of each month. If
any laboratory or IITF certification is
suspended or revoked, the laboratory or
IITF will be omitted from subsequent
lists until such time as it is restored to
full certification under the Mandatory
Guidelines.
If any laboratory or IITF has
withdrawn from the HHS National
Laboratory Certification Program (NLCP)
during the past month, it will be listed
at the end and will be omitted from the
monthly listing thereafter.
This notice is also available on the
internet at https://www.samhsa.gov/
workplace.
FOR FURTHER INFORMATION CONTACT:
Giselle Hersh, Division of Workplace
Programs, SAMHSA/CSAP, 5600
Fishers Lane, Room 16N03A, Rockville,
Maryland 20857; 240–276–2600 (voice).
SUPPLEMENTARY INFORMATION: The
Department of Health and Human
Services (HHS) notifies federal agencies
of the laboratories and Instrumented
Initial Testing Facilities (IITF) currently
certified to meet the standards of the
Mandatory Guidelines for Federal
Workplace Drug Testing Programs
(Mandatory Guidelines). The Mandatory
Guidelines were first published in the
Federal Register on April 11, 1988 (53
FR 11970), and subsequently revised in
the Federal Register on June 9, 1994 (59
FR 29908); September 30, 1997 (62 FR
51118); April 13, 2004 (69 FR 19644);
November 25, 2008 (73 FR 71858);
December 10, 2008 (73 FR 75122); April
30, 2010 (75 FR 22809); and on January
23, 2017 (82 FR 7920)
The Mandatory Guidelines were
initially developed in accordance with
SUMMARY:
E:\FR\FM\01FEN1.SGM
01FEN1
]]>Agencies
[Federal Register Volume 83, Number 22 (Thursday, February 1, 2018)]
[Notices]
[Pages 4667-4668]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02031]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Skeletal
Muscle and Exercise Physiology Study Section, February 8, 2018, 8:00
a.m. to February 9, 2018, 6:00 p.m., Hilton Long Beach and Executive
Center, 701 West Ocean Boulevard, Long Beach, CA 90831 which was
published in the Federal Register on January 19, 2018, 83 FR PG 2807.
[[Page 4668]]
The meeting will be held on February 7, 2018 at 6:00 p.m. and end
February 8, 2018 9:00 p.m. The meeting location remains the same. The
meeting is closed to the public.
Dated: January 29, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-02031 Filed 1-31-18; 8:45 am]
BILLING CODE 4140-01-P
